GC

Gayatri Chidananda Sindhe

Active Director Managing Director DIN 10969349
DIN 10969349 First appointment Feb 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Gayatri Chidananda Sindhe

Data last updated:

Gayatri Chidananda Sindhe is a Managing Director at Oltas Pharmaceutical Private Limited (since 2025).

DIN 10969349
Primary Designation Managing Director
First Appointment 25 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oltas Pharmaceutical Private Limited U46497KA2025PTC198582
Managing Director25 Feb 20252025Active

Board colleagues of Gayatri Chidananda Sindhe

NameDINCompanyDesignation
Chidananda Sindhe10969348Oltas Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oltas Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Gayatri Chidananda Sindhe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gayatri Chidananda Sindhe

Gayatri Chidananda Sindhe currently holds 1 directorship: Oltas Pharmaceutical Private Limited (Managing Director, since 25 Feb 2025).

Gayatri Chidananda Sindhe was first appointed on 25 Feb 2025 as Managing Director at Oltas Pharmaceutical Private Limited.

The current boards of Gayatri Chidananda Sindhe's companies include Chidananda Sindhe (Oltas Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available